Join to View Full Profile
1 Medical Center DrSection Of Hematology/IoncologyLebanon, NH 03756
Phone+1 603-650-5529
Fax+1 603-650-5830
Dr. Gautier is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 1990 - 1993
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1986 - 1990
Geisel School of Medicine at DartmouthClass of 1986
Certifications & Licensure
VT State Medical License 2005 - 2026
NH State Medical License 1999 - 2025
NC State Medical License 1991 - 2000
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia Start of enrollment: 2008 Jan 15
- Low Dose Melphalan and Bortezomib for AML and High-Risk MDS Start of enrollment: 2004 Sep 01
- A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsResults of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS)Hagop M. Kantarjian, Kebede H. Begna, Jessica K. Altman, Stuart L. Goldberg, Mikkael A. Sekeres
Cancer. 2021-08-23 - 27 citationsAn inhibitor of proteasome β2 sites sensitizes myeloma cells to immunoproteasome inhibitors.Sondra L. Downey-Kopyscinski, Ellen W. Daily, Marc Gautier, Ananta Bhatt, Bogdan I. Florea
Blood Advances. 2018-10-09 - 2 citationsPersistent increased troponin T in patient with thrombotic thrombocytopenic purpura responsive to treatment.Hong-Kee Lee, Marc Gautier, Brian C. Yu, Frank A. Polito, Timothy J. Brough
Clinica Chimica Acta; International Journal of Clinical Chemistry. 2010-06-03
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
